Differing severities of acute exacerbations of idiopathic pulmonary fibrosis (IPF): insights from the INPULSIS® trials

BACKGROUND: Given the broad definition of an acute exacerbation of IPF, it is likely that acute exacerbations are heterogeneous in their aetiology, severity and clinical course. We used pooled data from the INPULSIS® trials of nintedanib versus placebo to investigate whether acute exacerbations repo...

Descripción completa

Detalles Bibliográficos
Autores principales: Kreuter, Michael, Koegler, Harald, Trampisch, Matthias, Geier, Silke, Richeldi, Luca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6458653/
https://www.ncbi.nlm.nih.gov/pubmed/30971229
http://dx.doi.org/10.1186/s12931-019-1037-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6458653/
https://www.ncbi.nlm.nih.gov/pubmed/30971229
http://dx.doi.org/10.1186/s12931-019-1037-7

Ejemplares similares